FY 2024 Net Sales increased 0.1%, or
0.2% Organic increase
FY 2024 GAAP EPS decreased 11%,
Adjusted EPS increased 18%
Returned $90 Million to Shareholders via Dividends and
Share Repurchases for Fiscal Year 2024
Initiates Fiscal 2025 Outlook for growth in Organic Net Sales,
Adjusted EPS, Adjusted EBITDA and Free Cash Flow
SHELTON, Conn.,
Nov. 7,
2024 /PRNewswire/ -- Edgewell Personal Care
Company (NYSE: EPC) today announced results for its fourth fiscal
quarter 2024 and fiscal year ended,
September 30, 2024.
Executive Summary
- Net sales were $517.6 million, a
decrease of 3.1% compared to the prior year quarter. Full year net
sales were $2,253.7 million, an
increase of 0.1% compared to the prior year.
- Organic net sales decreased 2.8% for the quarter and increased
0.2% for the full year. (Organic basis excludes the impact from
currency movements.)
- GAAP Diluted net Earnings Per Share ("EPS") were $0.17 for the quarter and $1.97 for the fiscal year.
- Adjusted EPS were $0.72, for the
quarter, and $3.05 for the fiscal
year, inclusive of an $0.08
unfavorable impact from currency movements for the full fiscal
year. Adjusted EPS increased $0.46 or
18% compared to the prior year.
- Ended the fiscal fourth quarter with $209 million in cash on hand, access to an
additional $386 million revolving
credit facility and a net debt leverage ratio of 3.1x.
- Board of Directors declared a cash dividend of $0.15 per common share on October 31, 2024, for the fourth fiscal
quarter.
- Returned approximately $90
million to shareholders in the form of $59 million in share repurchases and $31 million of dividends in the fiscal year.
- Fiscal 2025 outlook for approximately 1% to 3% growth in
organic net sales and 7% growth in adjusted EPS, or 13% on a
constant currency basis, at the midpoint of the outlook range.
The Company reports results on a GAAP and non-GAAP basis and
has reconciled non-GAAP results to the most directly comparable
GAAP measures later in this release. See non-GAAP Financial
Measures for a more detailed explanation, including definitions of
various non-GAAP terms used in this release. All comparisons used
in this release are with the same period in the prior fiscal year
unless otherwise stated.
"For the fiscal year, we achieved slight organic net sales
growth, meaningfully expanded adjusted gross margins and delivered
double-digit adjusted earnings per share growth at constant
currency for the second consecutive fiscal year. In the face of a
heightened competitive landscape and an increasingly cautious
consumer, we accelerated organic growth across our international
businesses, introduced category-leading innovation in the US Sun
Care category and deepened our participation across the men's and
women's grooming segments. The strength of our business model
was reflected in our healthy earnings growth, substantial cash flow
generation and structural de-leveraging of the business," said
Rod Little, Edgewell's President and
Chief Executive Officer. "As we look to fiscal 2025, with strong
momentum across our International businesses, a strengthened
leadership team and increased focus on execution across the
organization, we anticipate a return to low single-digit organic
net sales growth, further margin and profit expansion, and
ultimately an increase in value creation for our
shareholders."
Fiscal 4Q 2024 Operating Results (Unaudited)
Net sales were $517.6
million in the quarter, a decrease of 3.1%, including a
$1.8 million unfavorable impact from
currency movements. Organic net sales decreased 2.8%. Growth
in international markets of 2.4%, driven largely by Wet Shave, was
more than offset by a 6% decline in North
America. Declines in Feminine Care, Shave Preps and Wet
One's were partly offset by mid-single-digit growth in Sun Care, although this growth was significantly
below expectations, due to adverse weather conditions in the U.S.in
August and September.
Gross profit was $212.8
million, as compared to $228.6
million in the prior year quarter. Gross margin as a
percent of net sales was 41.1%, a decrease of 170-basis
points. Adjusted gross margin increased 40-basis points, as
productivity savings of approximately 290-basis points more than
offset increased promotional levels (net of pricing) of
approximately 50-basis points, core inflation and lower volume
absorption of approximately 100-basis points, unfavorable mix and
other of approximately 80-basis points and an unfavorable currency
impact of approximately 20-basis points.
Selling, general and administrative expense
("SG&A") was $109.2
million, or 21.1%, of net sales, as compared to $112.4 million, or 21.0%, of net sales in the
prior year quarter. Adjusted SG&A as a percent of net sales was
essentially flat as lower incentive compensation expense and
operational efficiency savings offset higher people and consulting
expenses and the impact of lower net sales.
The Company recorded pre-tax restructuring and repositioning
expenses of $22.8 million in the
quarter, consisting largely of severance, project implementation
and other exit costs in support of cost efficiency programs. This
includes $15.6 million related to
certain operational and organizational steps designed to streamline
the Company's operations and supply chain by consolidating its
current Mexico operations in
Obregon and Mexico City into a single facility in
Aguascalientes, Mexico. The
Company also recorded $0.7 million in
acquisition and integration costs related to the Billie
acquisition.
Advertising and sales promotion expense
("A&P") was $44.1
million, or 8.5% of net sales, an increase of $3.8 million, compared to $40.3 million, or 7.5% of net sales in the prior
year quarter.
Operating income was $20.4
million, inclusive of a $2.0
million unfavorable impact from currency movements, compared
to $52.1 million in the prior year
quarter. Adjusted operating income was $56.0
million, or 10.8% of net sales, compared to $61.4 million, or 11.5%, of net sales in the
prior year quarter.
Interest expense associated with debt was
$17.5 million, compared to
$18.7 million in the prior year
period. The decrease in interest expense was the result of a lower
overall debt balance on the Company's revolving credit facility,
partially offset by higher interest rates.
Other (income) expense, net was $2.5 million of income compared to $0.1 million of expense in the prior year
quarter. Currency hedge and remeasurements gains were $4.0 million in the current quarter, compared to
$1.6 million in the prior year
quarter. Current year income also reflects higher interest income
compared to the prior year quarter.
The effective tax rate for fiscal 2024 was 18.5% compared
to 22.3% in the prior year period. The adjusted effective tax rate
for fiscal 2024 was 20.3%, down from the prior fiscal year adjusted
effective tax rate of 23.0%. The fiscal 2024 effective tax rate
reflects the favorable mix of earnings in lower tax rate
jurisdictions and the impact of a change in the Company's prior
estimates.
GAAP net earnings were $8.8
million or $0.17 per diluted
share compared to $29.9 million or
$0.58 per diluted share in the prior
year quarter. Adjusted net earnings were $35.8 million or $0.72 per share, inclusive of a $0.01
favorable impact from currency movements, compared to $37.3 million or $0.73 per share in the prior year quarter.
Adjusted EBITDA was $78.9 million,
inclusive of a $0.4 million favorable currency impact,
compared to $84.4 million in the
prior year quarter.
Net cash from operating activities was $231.0 million for the twelve months ended
September 30, 2024 compared to
$216.1 million in the twelve months
ended September 30, 2023. The
increase in cash from operating activities was driven by favorable
changes in working capital, partially offset by decreased
earnings.
Fiscal 4Q 2024 Operating Segment Results (Unaudited)
The following is a summary of fourth quarter results by
segment:
Wet Shave (Men's Systems, Women's Systems, Disposables,
and Shave Preps)
Net sales decreased $4.7 million,
or 1.5%. Organic net sales decreased $3.5
million or 1.1%, as growth in Men's and Women's Systems, was
more than offset by significant declines in Shave Preps in
North America. Wet Shave segment
profit increased $7.3 million, or
13.3%. Organic segment profit, excluding the unfavorable impact
from currency increased $8.7 million,
or 15.8%, primarily reflecting higher gross margin.
Sun and Skin Care (Sun
Care, Wet Ones, Bulldog, Jack
Black and Cremo)
Net sales decreased $5.3 million,
or 3.8%. Organic net sales decreased $4.8 million, or 3.5%, as low-single-digit growth
in Sun Care was more than offset by
significant declines in Wet One's and low-single-digit declines in
Grooming. Segment profit decreased $8.7
million, or 38.3%. Organic segment profit decreased
$8.3 million, or 36.6%, primarily
driven by lower gross margin and higher marketing and SG&A
expenses.
Feminine Care (Tampons, Pads, and Liners)
Net sales decreased $6.5 million,
or 8.9%, and organic net sales decreased $6.4 million, or 8.7%, as growth in Tampons was
more than offset by declines in Pads and Liners. Organic segment
profit decreased $5.4 million, or
46.6%, primarily reflecting lower gross margin.
Fiscal 2024 Operating Results (Unaudited)
Net sales were $2,253.7
million, an increase of $2.1
million, or 0.1%. Organic net sales increased 0.2%, as 7.3%
growth in international markets, reflecting both increased volumes
and price, was partly offset by a 3.8% decrease in North America organic net sales, primarily
reflecting volume declines in Feminine Care, Wet Shave and Wet
Ones, partly offset by organic growth across Sun Care and Grooming.
Gross Profit was $955.7
million, compared to $940.8
million in the prior year. Gross margin as a percent
of net sales was 42.4%, an increase of 60-basis points compared to
the prior year period. Adjusted gross margin increased 140-basis
points, as productivity savings of approximately 280-basis points
and favorable price of approximately 115-basis points, more than
offset core inflation and transitory cost headwinds related to
unfavorable absorption and heightened unit cost inflation trapped
in inventory of approximately 185-basis points, and unfavorable mix
of approximately 70-basis points.
Selling, general and administrative expense
("SG&A") was $430.1
million, or 19.1% of net sales, as compared to $409.6 million, or 18.2% of net sales in the
prior year. Adjusted SG&A as a percent of net sales increased
40-basis points, primarily driven by higher people expenses, legal
costs, and broker costs, partially offset by operational efficiency
savings, lower bad debt expense and lower incentive
compensation expense.
The Company recorded pre-tax restructuring and repositioning
expenses of $36.0 million, consisting
largely of severance, project implementation and other exit costs
in support of cost efficiency programs. This includes $15.6
million related to certain operational and organizational steps
designed to streamline the Company's operations and supply chain by
consolidating its current Mexico operations in Obregon and Mexico
City into a single facility in Aguascalientes, Mexico. The Company also
recorded $2.8 million in acquisition
and integration costs related to the Billie acquisition.
A&P was $232.0 million,
up $2.9 million from the prior year.
A&P as a percent of net sales increased to 10.3% from 10.2% in
the prior year.
Operating income, was $199.3
million, inclusive of $0.9
million unfavorable impact from currency movements, compared
to $227.0 million in the prior year.
Adjusted operating income was $267.2
million, or 11.9% of net sales, compared to $245.9 million, or 10.9% of net sales in the
prior year. The increase in adjusted operating income margin was
attributable to gross margin accretion, partially offset by higher
brand investment and people costs.
Interest expense associated with debt was
$76.5 million, compared to
$78.5 million in the prior year. The
decrease in interest expense was the result of a lower overall debt
balance on the Company's revolving credit facility, partially
offset by higher interest rates.
Other (income) expense, net was expense of $1.9 million compared to expense of $0.8 million in the prior year. Currency hedge
and remeasurement gains were $8.3
million in the current year, compared to $12.7 million in the prior year period. Current
year expense reflects lower pension expense compared to the prior
period, a loss on investment, and higher interest income. Prior
year expense includes the loss on the settlement of the
Canada defined benefit pension
plan of $7.9 million. On an adjusted
basis, other (income) expense, net was income of $1.2 million compared to income of $7.1 million in the prior year.
GAAP net earnings were $98.6
million or $1.97 per diluted
share compared to $114.7 million or
$2.21 per diluted share in the prior
year period. Adjusted net earnings were $153.0 million or $3.05 per share, inclusive of a $0.08 unfavorable impact from currency movements,
compared to $134.5 million or
$2.59 per share in the prior year
period, an increase of 21% at constant currency. Adjusted EBITDA
was $353.0 million, inclusive of a
$5.2 million unfavorable currency
impact, compared to $342.2
million in the prior year, an increase of 5% at constant
currency.
Capital Allocation
On October 31, 2024, the Board of
Directors declared a quarterly cash dividend of $0.15 per common share for the fourth fiscal
quarter. The dividend will be payable on January 8, 2025 to shareholders of record as of
the close of business on December 3,
2024. During the fourth quarter of fiscal 2024, the Company
paid dividends totaling $7.4 million
to stockholders.
During the fourth quarter of fiscal 2024, the Company completed
share repurchases of approximately 0.5 million shares at a total
cost of $18.3 million. For fiscal
2024, the Company completed share repurchases of 1.6 million shares
at a cost of $58.5 million. As of
September 30, 2024 the Company had
3.0 million shares of common stock available for repurchase in
the future under the Board's 2018 authorization.
Full Fiscal Year 2025 Financial Outlook
The Company is providing the following outlook assumptions for
fiscal 2025:
- Reported net sales are expected to increase in the range of
approximately 1.7% to 3.7%
- Includes an estimated 70-basis point positive impact from
foreign currency changes
- Organic net sales are expected to increase approximately 1% to
3%
- GAAP EPS is expected to be in the range of $2.59 to $2.79
- Includes: Restructuring and re-positioning charges*,
Sun Care reformulation, and Other
costs
- Adjusted EPS is expected to be in the range of $3.15 to $3.35
- Includes an estimated $0.18 EPS
unfavorable impact from foreign currency changes, including a
$0.10 unfavorable impact in Fiscal
Q1.
- Adjusted EPS at constant currency expected to increase
approximately 13% at the mid-point of the range
- Adjusted gross margin is expected to increase approximately
75-basis points, or 90-basis points at constant currency
- Adjusted operating margin is expected to increase approximately
40-basis points, or 50-basis points at constant currency
- The EPS outlook reflects the impact of expected share
repurchases of approximately $90
million
- Expect approximately two-thirds of adjusted net earnings to be
generated in the 2nd half of the fiscal year.
- Adjusted EBITDA is expected to be in the range of $356 to $368
million
- Includes an estimated $11 million
unfavorable impact from foreign currency changes
- Adjusted EBITDA at constant currency expected to increase
approximately 6% at the mid-point of the range
- Other Expense, net is expected to be approximately $7 million
- Interest expense associated with debt is expected to be
approximately $73 million
- Adjusted effective tax rate is expected to be approximately
22%
- Total depreciation and amortization expense expected to be
approximately $89 million
- Capital expenditures expected to be approximately 2.5% to 3.0%
of net sales
- Free cash flow is expected to be approximately $185 million
* In fiscal 2025, the Company is taking specific actions to
strengthen its operating model, simplify the organization and
improve manufacturing and supply chain efficiency through
restructuring and repositioning actions, including the
organizational and operational changes in Mexico. As a result of these actions, the
Company expects to incur pre-tax charges of approximately
$29 million for the full fiscal
year.
Webcast Information
In conjunction with this announcement, the Company will hold an
investor conference call beginning at 8:00
a.m. Eastern Time today. All interested parties may access a
live webcast of this conference call at www.edgewell.com, under the
"Investors," and "News and Events" tabs or by using the following
link: http://ir.edgewell.com/news-and-events/events
For those unable to participate during the live webcast, a
re-play will be available on www.edgewell.com, under the
"Investors," "Financial Reports," and "Quarterly Earnings" tabs.
This release includes references to the Company's website and
references to additional information and materials found on its
website. The Company's website and such information and materials
are not incorporated by reference in, and are not part of, this
release.
About Edgewell
Edgewell is a leading pure-play consumer products company with
an attractive, diversified portfolio of established brand names
such as Schick®, Wilkinson Sword® and Billie® men's and women's
shaving systems and disposable razors; Edge and Skintimate® shave
preparations; Playtex®, Stayfree®, Carefree® and o.b.® feminine
care products; Banana Boat®, Hawaiian Tropic®, Bulldog®, Jack
Black®, and CREMO® sun and skin care products; and Wet Ones®
products. The Company has a broad global footprint and operates in
more than 50 markets, including the U.S., Canada, Mexico, Germany, Japan, the U.K. and Australia, with approximately 6,700 employees
worldwide.
Forward-Looking Statements. This document contains
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934. You should not place undue reliance on these
statements. Forward-looking statements generally can be identified
by the use of words or phrases such as "believe," "expect,"
"expectation," "anticipate," "may," "could," "intend," "belief,"
"estimate," "plan," "target," "predict," "likely," "will,"
"should," "forecast," "outlook," or other similar words or phrases.
These statements are not based on historical facts, but instead
reflect the Company's expectations, estimates or projections
concerning future results or events, including, without limitation,
the future earnings and performance of Edgewell or any of its
businesses. Many factors outside our control could affect the
realization of these estimates. These statements are not guarantees
of performance and are inherently subject to known and unknown
risks, uncertainties and assumptions that are difficult to predict
and could cause the Company's actual results to differ materially
from those indicated by those statements. The Company cannot assure
you that any of its expectations, estimates or projections will be
achieved. The forward-looking statements included in this document
are only made as of the date of this document and the Company
disclaims any obligation to publicly update any forward-looking
statement to reflect subsequent events or circumstances, except as
required by law. You should not place undue reliance on these
statements.
In addition, other risks and uncertainties not presently known
to the Company or that it presently considers immaterial could
significantly affect the accuracy of any such forward-looking
statements. Risks and uncertainties include those detailed from
time to time in the Company's publicly filed documents, including
in Item 1A. Risk Factors of Part I of the Company's Annual Report
on Form 10-K filed with the Securities and Exchange Commission on
November 28, 2023.
Non-GAAP Financial Measures. While the Company
reports financial results in accordance with generally accepted
accounting principles ("GAAP") in the U.S., this discussion also
includes non-GAAP measures. These non-GAAP measures are referred to
as "adjusted" or "organic" and exclude items which are considered
by the Company as unusual or non-recurring and which may have a
disproportionate positive or negative impact on the Company's
financial results in any particular period. Reconciliations of
non-GAAP measures, including reconciliations of measures related to
the Company's fiscal 2024 financial outlook, are included within
the Notes to Condensed Consolidated Financial Statements included
with this release.
This non-GAAP information is provided as a supplement to, not as
a substitute for, or as superior to, measures of financial
performance prepared in accordance with GAAP. The Company uses this
non-GAAP information internally to make operating decisions and
believes it is helpful to investors because it allows more
meaningful period-to-period comparisons of ongoing operating
results. The information can also be used to perform analysis and
to better identify operating trends that may otherwise be masked or
distorted by the types of items that are excluded. This non-GAAP
information is a component in determining management's incentive
compensation. Finally, the Company believes this information
provides a higher degree of transparency. The following provides
additional detail on the Company's non-GAAP measures:
- The Company utilizes "adjusted" non-GAAP measures including
gross profit, SG&A, operating income, income taxes, net
earnings, diluted earnings per share, and EBITDA to internally make
operating decisions.
- Constant currency measures are calculated by removing the
impact of translational and transactional foreign currencies
changes, net of foreign currency hedges compared to the prior year.
Transactional foreign currency changes are driven by foreign legal
entities' transactions not denominated in local currency.
- The Company analyzes its net sales and segment profit on an
organic basis to better measure the comparability of results
between periods. Organic net sales and organic segment profit
exclude the impact of changes in foreign currency and the impact of
acquisitions.
- Segment profit will be impacted by fluctuations in translation
and transactional foreign currency. The impact of currency was
applied to segments using management's best estimate.
- Free cash flow is defined as net cash from operating
activities, less capital expenditures plus collections of deferred
purchase price of accounts receivable sold and proceeds from sales
of fixed assets. Free cash flow conversion is defined as free cash
flow as a percentage of net earnings adjusted for the net impact of
non-cash impairments.
- Net debt is defined as Gross debt less cash. Net debt leverage
ratio is defined as net debt divided by trailing twelve month
adjusted EBITDA.
Basis of Presentation. The financial results included
herein represent the most current information available to
management and are preliminary until the Company's Annual Report on
Form 10-K is filed with the SEC. Actual results may differ from
these preliminary results and are subject to the completion of
year-end accounting procedures and adjustments and the audit of the
Company's consolidated financial statements.
EDGEWELL PERSONAL
CARE COMPANY
CONDENSED
CONSOLIDATED STATEMENTS OF EARNINGS
(unaudited, in
millions, except per share data)
|
|
Three Months
Ended
September 30,
|
|
Twelve Months
Ended
September 30,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
|
|
|
|
|
|
|
Net sales
|
$
517.6
|
|
$
534.1
|
|
$
2,253.7
|
|
$
2,251.6
|
Cost of products
sold
|
304.8
|
|
305.5
|
|
1,298.0
|
|
1,310.8
|
Gross
profit
|
212.8
|
|
228.6
|
|
955.7
|
|
940.8
|
|
|
|
|
|
|
|
|
Selling, general and
administrative expense
|
109.2
|
|
112.4
|
|
430.1
|
|
409.6
|
Advertising and sales
promotion expense
|
44.1
|
|
40.3
|
|
232.0
|
|
229.1
|
Research and
development expense
|
16.3
|
|
15.9
|
|
58.4
|
|
58.5
|
Restructuring
charges
|
22.8
|
|
7.9
|
|
35.9
|
|
16.6
|
Operating
income
|
20.4
|
|
52.1
|
|
199.3
|
|
227.0
|
Interest expense
associated with debt
|
17.5
|
|
18.7
|
|
76.5
|
|
78.5
|
Other (income) expense,
net
|
(2.5)
|
|
0.1
|
|
1.9
|
|
0.8
|
Earnings before
income taxes
|
5.4
|
|
33.3
|
|
120.9
|
|
147.7
|
Income tax
provision
|
(3.4)
|
|
3.4
|
|
22.3
|
|
33.0
|
Net
earnings
|
$
8.8
|
|
$
29.9
|
|
$
98.6
|
|
$
114.7
|
|
|
|
|
|
|
|
|
Earnings per
share:
|
|
|
|
|
|
|
|
Basic net earnings per share
|
$
0.18
|
|
$
0.59
|
|
1.98
|
|
2.24
|
Diluted net earnings per diluted share
|
$
0.17
|
|
$
0.58
|
|
$
1.97
|
|
$
2.21
|
|
|
|
|
|
|
|
|
Weighted-average
shares outstanding:
|
|
|
|
|
|
|
|
Basic
|
49.2
|
|
50.6
|
|
49.7
|
|
51.2
|
Diluted
|
49.9
|
|
51.3
|
|
50.1
|
|
51.8
|
See Accompanying
Notes.
|
EDGEWELL PERSONAL
CARE COMPANY
CONDENSED
CONSOLIDATED BALANCE SHEETS
(unaudited, in
millions)
|
|
September
30,
2024
|
|
September
30,
2023
|
Assets
|
|
|
|
Current
assets
|
|
|
|
Cash and cash
equivalents
|
$
209.1
|
|
$
216.4
|
Trade receivables,
less allowance for doubtful accounts
|
109.4
|
|
106.2
|
Inventories
|
477.3
|
|
492.4
|
Other current
assets
|
140.2
|
|
147.4
|
Total current
assets
|
936.0
|
|
962.4
|
Property, plant and
equipment, net
|
349.1
|
|
337.9
|
Goodwill
|
1,338.6
|
|
1,331.4
|
Other intangible
assets, net
|
948.5
|
|
973.8
|
Other assets
|
158.7
|
|
135.2
|
Total
assets
|
$
3,730.9
|
|
$
3,740.7
|
|
|
|
|
Liabilities and
Shareholders' Equity
|
|
|
|
Current
liabilities
|
|
|
|
Notes
payable
|
$
24.5
|
|
$
19.5
|
Accounts
payable
|
219.3
|
|
194.4
|
Other current
liabilities
|
319.8
|
|
309.5
|
Total current
liabilities
|
563.6
|
|
523.4
|
Long-term
debt
|
1,275.0
|
|
1,360.7
|
Deferred income tax
liabilities
|
133.2
|
|
136.4
|
Other
liabilities
|
175.0
|
|
179.7
|
Total
liabilities
|
2,146.8
|
|
2,200.2
|
Shareholders'
equity
|
|
|
|
Common
shares
|
0.7
|
|
0.7
|
Additional paid-in
capital
|
1,586.0
|
|
1,593.8
|
Retained
earnings
|
1,090.1
|
|
1,022.1
|
Common shares in
treasury at cost
|
(937.9)
|
|
(906.1)
|
Accumulated other
comprehensive loss
|
(154.8)
|
|
(170.0)
|
Total shareholders'
equity
|
1,584.1
|
|
1,540.5
|
Total liabilities
and shareholders' equity
|
$
3,730.9
|
|
$
3,740.7
|
See Accompanying
Notes.
|
EDGEWELL PERSONAL
CARE COMPANY
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited, in
millions)
|
|
Twelve Months
Ended
September 30,
|
|
2024
|
|
2023
|
Cash Flow from
Operating Activities
|
|
|
|
Net
earnings
|
$
98.6
|
|
$
114.7
|
Depreciation and
amortization
|
88.0
|
|
91.4
|
Share-based
compensation expense
|
26.5
|
|
27.5
|
Deferred income
taxes
|
(9.6)
|
|
(4.5)
|
Deferred compensation
payments
|
(2.1)
|
|
(4.9)
|
Defined benefit
settlement loss
|
—
|
|
7.9
|
Loss on sale of
assets
|
0.7
|
|
2.5
|
Other, net
|
(18.7)
|
|
(23.5)
|
Changes in current
assets and liabilities used in operations
|
47.6
|
|
5.0
|
Net cash from operating
activities
|
231.0
|
|
216.1
|
|
|
|
|
Cash Flow from
Investing Activities
|
|
|
|
Capital
expenditures
|
(56.5)
|
|
(49.5)
|
Collection of deferred
purchase price from accounts receivable sold
|
0.7
|
|
2.7
|
Other, net
|
(6.6)
|
|
(3.7)
|
Net cash used by
investing activities
|
(62.4)
|
|
(50.5)
|
|
|
|
|
Cash Flow from
Financing Activities
|
|
|
|
Cash proceeds from
debt with original maturities greater than 90 days
|
813.0
|
|
841.0
|
Cash payments on debt
with original maturities greater than 90 days
|
(901.0)
|
|
(874.0)
|
Proceeds from debt
with original maturities of 90 days or less
|
4.2
|
|
—
|
Repurchase of
shares
|
(58.5)
|
|
(75.2)
|
Dividends to common
shareholders
|
(30.7)
|
|
(31.5)
|
Employee shares
withheld for taxes
|
(7.3)
|
|
(9.0)
|
Net financing inflow
from the Accounts Receivable Facility
|
5.2
|
|
2.3
|
Other, net
|
(4.3)
|
|
(0.1)
|
Net cash used by
financing activities
|
(179.4)
|
|
(146.5)
|
|
|
|
|
Effect of exchange rate
changes on cash
|
3.5
|
|
8.6
|
|
|
|
|
Net (decrease) increase
in cash and cash equivalents
|
(7.3)
|
|
27.7
|
Cash and cash
equivalents, beginning of period
|
216.4
|
|
188.7
|
Cash and cash
equivalents, end of period
|
$
209.1
|
|
$
216.4
|
See Accompanying
Notes.
|
EDGEWELL PERSONAL CARE COMPANY
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited,
in millions, except per share data)
Note 1 — Segments
The Company conducts its business in the following three
segments: Wet Shave, Sun and Skin Care, and Feminine Care
(collectively, the "Segments," and each individually, a "Segment").
Segment performance is evaluated based on segment profit, exclusive
of general corporate expenses, share-based compensation costs,
items which are considered by the Company to be unusual or
non-recurring and which may have a disproportionate positive or
negative impact on the Company's financial results in any
particular period and the amortization of intangible assets.
Financial items, such as interest income and expense, are managed
on a global basis at the corporate level. The exclusion of such
charges from segment results reflects management's view on how it
evaluates segment performance.
Segment net sales and profitability are presented below:
|
Three Months
Ended
September 30,
|
|
Twelve Months
Ended
September 30,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net Sales
|
|
|
|
|
|
|
|
Wet Shave
|
$
318.2
|
|
$
322.9
|
|
$
1,229.3
|
|
$
1,230.9
|
Sun and Skin
Care
|
132.7
|
|
138.0
|
|
740.8
|
|
705.5
|
Feminine
Care
|
66.7
|
|
73.2
|
|
283.6
|
|
315.2
|
Total net
sales
|
$
517.6
|
|
$
534.1
|
|
$
2,253.7
|
|
$
2,251.6
|
|
|
|
|
|
|
|
|
Segment
Profit
|
|
|
|
|
|
|
|
Wet Shave
|
$
62.2
|
|
$
54.9
|
|
$
203.9
|
|
$
158.3
|
Sun and Skin
Care
|
14.0
|
|
22.7
|
|
131.3
|
|
137.4
|
Feminine
Care
|
6.2
|
|
11.6
|
|
28.8
|
|
49.7
|
Total segment
profit
|
82.4
|
|
89.2
|
|
364.0
|
|
345.4
|
General corporate and
other expenses
|
(18.6)
|
|
(20.1)
|
|
(65.7)
|
|
(68.7)
|
Restructuring and
repositioning expenses
|
(22.8)
|
|
(8.0)
|
|
(36.0)
|
|
(17.1)
|
Acquisition and
integration costs
|
(4.0)
|
|
(2.4)
|
|
(6.1)
|
|
(7.5)
|
SKU
Rationalization
|
—
|
|
1.7
|
|
—
|
|
1.7
|
Sun Care
reformulation
|
(2.2)
|
|
(0.2)
|
|
(4.4)
|
|
(1.9)
|
Wet Ones manufacturing
plant fire
|
(4.2)
|
|
—
|
|
(12.2)
|
|
—
|
Legal
matters
|
—
|
|
—
|
|
(3.9)
|
|
6.3
|
Loss on
investment
|
—
|
|
—
|
|
(3.1)
|
|
—
|
Pension settlement
expense
|
—
|
|
(0.7)
|
|
—
|
|
(7.9)
|
Other projects
costs
|
(2.4)
|
|
(0.4)
|
|
(5.3)
|
|
(0.4)
|
Amortization of
intangibles
|
(7.8)
|
|
(7.7)
|
|
(31.1)
|
|
(30.8)
|
Interest and other
expense, net
|
(15.0)
|
|
(18.1)
|
|
(75.3)
|
|
(71.4)
|
Total earnings before
income taxes
|
$
5.4
|
|
$
33.3
|
|
$
120.9
|
|
$
147.7
|
Refer to Note 2 - GAAP to Non-GAAP Reconciliations for the
income statement location of non-GAAP adjustments to earnings
before income taxes.
Note 2 — GAAP to Non-GAAP Reconciliations
The following tables provide a GAAP to Non-GAAP reconciliation
of certain line items from the Condensed Consolidated Statement of
Earnings:
Three Months Ended
September 30, 2024
|
|
|
|
|
|
|
|
|
|
Gross
Profit
|
|
SG&A
|
|
Operating
Income
|
|
EBIT
(1)
|
|
Income
Taxes
|
|
Net
Earnings
|
|
Diluted
EPS
|
GAAP -
Reported
|
$ 212.8
|
|
$ 109.2
|
|
$ 20.4
|
|
$
5.4
|
|
$
(3.4)
|
|
$
8.8
|
|
$
0.17
|
Restructuring and
repositioning expenses
|
—
|
|
—
|
|
22.8
|
|
22.8
|
|
5.5
|
|
17.3
|
|
0.35
|
Acquisition and
integration costs
|
3.3
|
|
0.7
|
|
4.0
|
|
4.0
|
|
1.0
|
|
3.0
|
|
0.06
|
Sun Care
reformulation
|
—
|
|
—
|
|
2.2
|
|
2.2
|
|
0.6
|
|
1.6
|
|
0.03
|
Wet Ones manufacturing
plant fire
|
4.2
|
|
—
|
|
4.2
|
|
4.2
|
|
1.0
|
|
3.2
|
|
0.07
|
Other project
costs
|
—
|
|
2.4
|
|
2.4
|
|
2.4
|
|
0.5
|
|
1.9
|
|
0.04
|
Total Adjusted
Non-GAAP
|
$ 220.3
|
|
$ 106.1
|
|
$ 56.0
|
|
$
41.0
|
|
$
5.2
|
|
$ 35.8
|
|
$
0.72
|
|
|
|
|
|
|
|
Adjusted Non-GAAP
Constant Currency
|
|
$
0.71
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP as a percent of
net sales
|
41.1 %
|
|
21.1 %
|
|
3.9 %
|
|
GAAP effective tax
rate
|
(62.9) %
|
|
|
Adjusted as a percent
of net sales
|
42.6 %
|
|
20.5 %
|
|
10.8 %
|
|
Adjusted effective tax
rate
|
12.8 %
|
|
|
Adjusted Constant
Currency as a percent of net sales
|
42.8 %
|
|
|
|
11.1 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Twelve Months Ended
September 30, 2024
|
|
|
|
|
|
|
|
|
|
|
|
Gross
Profit
|
|
SG&A
|
|
Operating
Income
|
|
EBIT (1)
|
|
Income
Taxes
|
|
Net
Earnings
|
|
Diluted
EPS
|
GAAP -
Reported
|
$ 955.7
|
|
$ 430.1
|
|
$ 199.3
|
|
$
120.9
|
|
$
22.3
|
|
$ 98.6
|
|
$
1.97
|
Restructuring and
repositioning expenses
|
—
|
|
0.1
|
|
36.0
|
|
36.0
|
|
8.8
|
|
27.2
|
|
0.54
|
Acquisition and
integration costs
|
3.3
|
|
2.8
|
|
6.1
|
|
6.1
|
|
1.5
|
|
4.6
|
|
0.09
|
Sun Care
reformulation
|
—
|
|
—
|
|
4.4
|
|
4.4
|
|
1.1
|
|
3.3
|
|
0.07
|
Wet Ones manufacturing
plant fire
|
12.2
|
|
—
|
|
12.2
|
|
12.2
|
|
3.0
|
|
9.2
|
|
0.18
|
Legal
matters
|
—
|
|
3.9
|
|
3.9
|
|
3.9
|
|
1.0
|
|
2.9
|
|
0.06
|
Loss on
investment
|
—
|
|
—
|
|
—
|
|
3.1
|
|
—
|
|
3.1
|
|
0.06
|
Other project
costs
|
$
—
|
|
$
5.3
|
|
$
5.3
|
|
$
5.3
|
|
$
1.2
|
|
$
4.1
|
|
$
0.08
|
Total Adjusted
Non-GAAP
|
$ 971.2
|
|
$ 418.0
|
|
$ 267.2
|
|
$
191.9
|
|
$
38.9
|
|
$ 153.0
|
|
$
3.05
|
|
|
|
|
|
|
|
Adjusted Non-GAAP
Constant Currency
|
|
$
3.13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP as a percent of
net sales
|
42.4 %
|
|
19.1 %
|
|
8.8 %
|
|
GAAP effective tax
rate
|
18.5 %
|
|
|
Adjusted as a percent
of net sales
|
43.1 %
|
|
18.5 %
|
|
11.9 %
|
|
Adjusted effective tax
rate
|
20.3 %
|
|
|
Adjusted Constant
Currency as a percent of net sales
|
43.1 %
|
|
|
|
11.9 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, 2023
|
|
|
|
|
|
|
|
|
|
|
|
Gross
Profit
|
|
SG&A
|
|
Operating
Income
|
|
EBIT (1)
|
|
Income
Taxes
|
|
Net
Earnings
|
|
Diluted
EPS
|
GAAP -
Reported
|
$ 228.6
|
|
$ 112.4
|
|
$ 52.1
|
|
$
33.3
|
|
$
3.4
|
|
$ 29.9
|
|
0.58
|
Restructuring and
repositioning expenses
|
—
|
|
0.1
|
|
8.0
|
|
8.0
|
|
2.0
|
|
6.0
|
|
0.12
|
Acquisition and
integration costs
|
—
|
|
2.4
|
|
2.4
|
|
2.4
|
|
0.6
|
|
1.8
|
|
0.04
|
SKU
rationalization
|
(1.7)
|
|
—
|
|
(1.7)
|
|
(1.7)
|
|
(0.4)
|
|
(1.3)
|
|
(0.03)
|
Sun Care reformulation
(2)
|
(1.4)
|
|
—
|
|
0.2
|
|
0.2
|
|
0.1
|
|
0.1
|
|
—
|
Pension settlement
expense
|
—
|
|
—
|
|
—
|
|
0.7
|
|
0.2
|
|
0.5
|
|
0.01
|
Other project
costs
|
—
|
|
0.4
|
|
0.4
|
|
0.4
|
|
0.1
|
|
0.3
|
|
0.01
|
Total Adjusted
Non-GAAP
|
$ 225.5
|
|
$ 109.5
|
|
$ 61.4
|
|
$
43.3
|
|
$
6.0
|
|
$ 37.3
|
|
$
0.73
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP as a percent of
net sales
|
42.8 %
|
|
21.0 %
|
|
9.8 %
|
|
GAAP effective tax
rate
|
10.2 %
|
|
|
Adjusted as a percent
of net sales
|
42.2 %
|
|
20.5 %
|
|
11.5 %
|
|
Adjusted effective tax
rate
|
13.9 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Twelve Months Ended
September 30, 2023
|
|
|
|
|
|
|
|
|
|
|
|
Gross
Profit
|
|
SG&A
|
|
Operating
Income
|
|
EBIT (1)
|
|
Income
Taxes
|
|
Net
Earnings
|
|
Diluted
EPS
|
GAAP -
Reported
|
$ 940.8
|
|
$ 409.6
|
|
$ 227.0
|
|
$
147.7
|
|
$
33.0
|
|
$ 114.7
|
|
$
2.21
|
Restructuring and
repositioning expenses
|
0.2
|
|
0.3
|
|
17.1
|
|
17.1
|
|
4.4
|
|
12.7
|
|
0.24
|
Acquisition and
integration costs
|
—
|
|
7.5
|
|
7.5
|
|
7.5
|
|
1.8
|
|
5.7
|
|
0.11
|
SKU
rationalization
|
(1.7)
|
|
—
|
|
(1.7)
|
|
(1.7)
|
|
(0.4)
|
|
(1.3)
|
|
(0.03)
|
Sun Care reformulation
costs (2)
|
(1.4)
|
|
—
|
|
1.9
|
|
1.9
|
|
0.5
|
|
1.4
|
|
0.03
|
Legal
matters
|
—
|
|
(6.3)
|
|
(6.3)
|
|
(6.3)
|
|
(1.5)
|
|
(4.8)
|
|
(0.09)
|
Pension settlement
expense
|
—
|
|
—
|
|
—
|
|
7.9
|
|
2.1
|
|
5.8
|
|
0.11
|
Other project
costs
|
—
|
|
0.4
|
|
0.4
|
|
0.4
|
|
0.1
|
|
0.3
|
|
0.01
|
Total Adjusted
Non-GAAP
|
$ 937.9
|
|
$ 407.7
|
|
$ 245.9
|
|
$
174.5
|
|
$
40.0
|
|
$ 134.5
|
|
$
2.59
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP as a percent of
net sales
|
41.8 %
|
|
18.2 %
|
|
10.1 %
|
|
GAAP effective tax
rate
|
22.3 %
|
|
|
Adjusted as a percent
of net sales
|
41.7 %
|
|
18.1 %
|
|
10.9 %
|
|
Adjusted effective tax
rate
|
23.0 %
|
|
|
|
(1) EBIT is defined as
Earnings (loss) before income taxes.
|
(2) Also includes
pre-tax R&D costs related to the reformulation, recall, and
destruction of certain Sun Care products
|
Note 3 - Net Sales and Profit by Segment
Operations for the Company are reported via three Segments. The
following tables present changes in net sales and segment profit
for the fourth quarter and fiscal year 2023, as compared to the
corresponding period in the prior year.
Net Sales (In
millions - Unaudited)
|
Three Months Ended
September 30, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wet
Shave
|
|
Sun and Skin
Care
|
|
Feminine
Care
|
|
Total
|
Net Sales - Q4
'23
|
$
322.9
|
|
|
|
$
138.0
|
|
|
|
$ 73.2
|
|
|
|
$
534.1
|
|
|
Organic
|
(3.5)
|
|
(1.1) %
|
|
(4.8)
|
|
(3.5) %
|
|
(6.4)
|
|
(8.7) %
|
|
(14.7)
|
|
(2.8) %
|
Impact of
currency
|
(1.2)
|
|
(0.4) %
|
|
(0.5)
|
|
(0.3) %
|
|
(0.1)
|
|
(0.2) %
|
|
(1.8)
|
|
(0.3) %
|
Net Sales - Q4
'24
|
$
318.2
|
|
(1.5) %
|
|
$
132.7
|
|
(3.8) %
|
|
$ 66.7
|
|
(8.9) %
|
|
$
517.6
|
|
(3.1) %
|
|
Net Sales (In
millions - Unaudited)
|
Twelve Months Ended
September 30, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wet
Shave
|
|
Sun and Skin
Care
|
|
Feminine
Care
|
|
Total
|
Net Sales - FY
'23
|
$ 1,230.9
|
|
|
|
$
705.5
|
|
|
|
$
315.2
|
|
|
|
$ 2,251.6
|
|
|
Organic
|
3.0
|
|
0.2 %
|
|
32.8
|
|
4.6 %
|
|
(31.5)
|
|
(10.0) %
|
|
4.3
|
|
0.2 %
|
Impact of
currency
|
(4.6)
|
|
(0.3) %
|
|
2.5
|
|
0.4 %
|
|
(0.1)
|
|
— %
|
|
(2.2)
|
|
(0.1) %
|
Net Sales - FY
'24
|
$ 1,229.3
|
|
(0.1) %
|
|
$
740.8
|
|
5.0 %
|
|
$
283.6
|
|
(10.0) %
|
|
$ 2,253.7
|
|
0.1 %
|
|
Segment Profit (In
millions - Unaudited)
|
Three Months Ended
September 30, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wet
Shave
|
|
Sun and Skin
Care
|
|
Feminine
Care
|
|
Total
|
Segment Profit - Q4
'23
|
$ 54.9
|
|
|
|
$ 22.7
|
|
|
|
$ 11.6
|
|
|
|
$ 89.2
|
|
|
Organic
|
8.7
|
|
15.8 %
|
|
(8.3)
|
|
(36.6) %
|
|
(5.4)
|
|
(46.6) %
|
|
(5.0)
|
|
(5.6) %
|
Impact of
currency
|
(1.4)
|
|
(2.5) %
|
|
(0.4)
|
|
(1.7) %
|
|
—
|
|
— %
|
|
(1.8)
|
|
(2.0) %
|
Segment Profit - Q4
'24
|
$ 62.2
|
|
13.3 %
|
|
$ 14.0
|
|
(38.3) %
|
|
$ 6.2
|
|
(46.6) %
|
|
$ 82.4
|
|
(7.6) %
|
|
Segment Profit (In
millions - Unaudited)
|
Twelve Months Ended
September 30, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wet
Shave
|
|
Sun and Skin
Care
|
|
Feminine
Care
|
|
Total
|
Segment Profit - FY
'23
|
$
158.3
|
|
|
|
$
137.4
|
|
|
|
$ 49.7
|
|
|
|
$
345.4
|
|
|
Organic
|
47.4
|
|
29.9 %
|
|
(7.3)
|
|
(5.3) %
|
|
(20.8)
|
|
(41.9) %
|
|
19.3
|
|
5.6 %
|
Impact of
currency
|
(1.8)
|
|
(1.1) %
|
|
1.2
|
|
0.9 %
|
|
(0.1)
|
|
(0.2) %
|
|
(0.7)
|
|
(0.2) %
|
Segment Profit - FY
'24
|
$
203.9
|
|
28.8 %
|
|
$
131.3
|
|
(4.4) %
|
|
$ 28.8
|
|
(42.1) %
|
|
$
364.0
|
|
5.4 %
|
For all tables, the impact of currency to segment profit
includes both the translational and transactional currency changes
during the quarter.
Note 4 - Net Debt and EBITDA
The Company reports financial results on a GAAP and adjusted
basis. The tables below are used to reconcile Net Debt and Net
earnings to EBITDA and Adjusted EBITDA, which are Non-GAAP
measures, to improve comparability of results between periods.
|
|
|
|
|
September
30,
|
|
|
|
|
|
2024
|
|
2023
|
Notes
payable
|
|
|
|
|
$
24.5
|
|
$
19.5
|
Long-term
debt
|
|
|
|
|
1,275.0
|
|
1,360.7
|
Gross debt
|
|
|
|
|
$
1,299.5
|
|
$
1,380.2
|
Less: Cash and cash
equivalents
|
|
|
|
|
209.1
|
|
216.4
|
Net Debt
|
|
|
|
|
$
1,090.4
|
|
$
1,163.8
|
|
|
|
|
|
Three Months
Ended
September 30,
|
|
Twelve Months
Ended
September 30,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net
earnings
|
$
8.8
|
|
$
29.9
|
|
$
98.6
|
|
$
114.7
|
Income tax
provision
|
(3.4)
|
|
3.4
|
|
22.3
|
|
33.0
|
Interest expense,
net
|
16.5
|
|
17.9
|
|
73.1
|
|
76.4
|
Depreciation and
amortization
|
21.4
|
|
23.2
|
|
88.0
|
|
91.3
|
EBITDA
|
$
43.3
|
|
$
74.4
|
|
$
282.0
|
|
$
315.4
|
|
|
|
|
|
|
|
|
Restructuring and
repositioning expenses
|
22.8
|
|
8.0
|
|
36.0
|
|
17.1
|
Acquisition and
integration planning costs
|
4.0
|
|
2.4
|
|
6.1
|
|
7.5
|
SKU
rationalization
|
—
|
|
(1.7)
|
|
—
|
|
(1.7)
|
Sun Care
reformulation
|
2.2
|
|
0.2
|
|
4.4
|
|
1.9
|
Wet Ones manufacturing
plant fire
|
4.2
|
|
—
|
|
12.2
|
|
—
|
Legal
matters
|
—
|
|
—
|
|
3.9
|
|
(6.3)
|
Loss on
investment
|
—
|
|
—
|
|
3.1
|
|
—
|
Pension settlement
expense
|
—
|
|
0.7
|
|
—
|
|
7.9
|
Other project
costs
|
2.4
|
|
0.4
|
|
5.3
|
|
0.4
|
Adjusted
EBITDA
|
$
78.9
|
|
$
84.4
|
|
$
353.0
|
|
$
342.2
|
|
|
|
|
|
|
|
|
Note 5 - Outlook
The following tables provide reconciliations of Adjusted EPS and
Adjusted EBITDA, Non-GAAP measures, included within the Company's
outlook for projected fiscal 2025 results:
Adjusted EPS
Outlook
|
|
|
Fiscal 2025 GAAP
EPS
|
approx.
|
$2.59 -
$2.79
|
|
|
|
Restructuring and
repositioning costs
|
approx.
|
0.60
|
Sun Care reformulation
costs
|
approx.
|
0.11
|
Other costs
|
approx.
|
0.06
|
Income
taxes(1)
|
approx.
|
(0.21)
|
|
|
|
Fiscal 2025 Adjusted
EPS Outlook (Non-GAAP)
|
approx.
|
$3.15 -
$3.35
|
(1) Income tax effect of the
adjustments to Fiscal 2025 GAAP EPS noted above.
|
|
|
|
Adjusted EBITDA
Outlook
|
|
|
Fiscal 2025 GAAP Net
Income
|
approx.
|
$126 - $136
|
Income tax
provision
|
approx.
|
35
|
Interest expense,
net
|
approx.
|
70
|
Depreciation and
amortization
|
approx.
|
89
|
EBITDA
|
approx.
|
$319 - $331
|
|
|
|
Restructuring and
repositioning costs
|
approx.
|
29
|
Sun Care reformulation
costs
|
approx.
|
5
|
Other costs
|
approx.
|
3
|
Fiscal 2025 Adjusted
EBITDA
|
approx.
|
$356 - $368
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/edgewell-personal-care-announces-fourth-quarter-and-fiscal-2024-results-provides-2025-outlook-302298128.html
SOURCE Edgewell Personal Care Company